📰 Segments Profiled News
Page 26 - Segments Profiled News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.
March 8, 2023
During the forecast period 2023 to 2033, the Hutchinson Gilford progeria syndrome market is expected to grow at a value of 8.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Hutchinson Gilford progeria syndrome is expected to rise up to a market valuation of US$ 15,990 Million. A...
March 8, 2023
As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to...
March 8, 2023
A recently published study by FMI expects the global thrombocytopenia treatment market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 10 Billion is expected for the market. The thrombocytopenia treatment market is predicted to increase significantly, since p...
March 7, 2023
During the forecast period 2023 to 2033, the 3D printed prosthetics market is expected to grow at a value of 8% CAGR, according to Future Market Insights. By the year 2033, the global market for 3D printed prosthetics is expected to rise up to a market valuation of US$ 3.5 Billion. The major factor driving the marke...
March 6, 2023
The global antibody-mediated rejection prevention market is predicted to reach a valuation of US$ 89 million in 2023, with a compound annual growth rate (CAGR) of 16%, as per a recently published FMI report. Over the last decade, the complement system has emerged as an important constituent of the AMR market.Technol...
March 6, 2023
During the forecast period 2023 to 2033, the Eosinophilia therapeutics market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Eosinophilia therapeutics is expected to rise up to a market valuation of US$ 739.62 Million. Growth of the market can...
March 3, 2023
The global Monoclonal Antibodies Market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion by 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1...
March 3, 2023
A recently published study by FMI expects the global high potency API contract manufacturing market to augment at a 7% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 8 Billion is expected for the market.Rising breakthroughs in high potency API (HPAPI) manufacturing technologies,...
March 3, 2023
During the forecast period 2023 to 2033, the Congenital Adrenal Hyperplasia treatment market is expected to grow at a value of 8.1% CAGR, according to Future Market Insights. By the year 2033, the global market for Congenital Adrenal Hyperplasia treatment is expected to rise up to a market valuation of US$ 892 Milli...
March 3, 2023
During the forecast period 2023 to 2033, the atypical hemolytic uremic syndrome (ahus) treatment market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Atypical hemolytic uremic syndrome (ahus) treatment is expected to rise up to a market valu...